These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28199791)
1. Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems. Al-Gousous J; Tsume Y; Fu M; Salem II; Langguth P Mol Pharm; 2017 Dec; 14(12):4209-4219. PubMed ID: 28199791 [TBL] [Abstract][Full Text] [Related]
2. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Kambayashi A; Blume H; Dressman J Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057 [TBL] [Abstract][Full Text] [Related]
4. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release. Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141 [TBL] [Abstract][Full Text] [Related]
5. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation. Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications. Al-Gousous J; Ruan H; Blechar JA; Sun KX; Salehi N; Langguth P; Job NM; Lipka E; Loebenberg R; Bermejo M; Amidon GE; Amidon GL Eur J Pharm Biopharm; 2019 Jun; 139():47-58. PubMed ID: 30872012 [TBL] [Abstract][Full Text] [Related]
7. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus. Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257 [TBL] [Abstract][Full Text] [Related]
8. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles. Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282 [TBL] [Abstract][Full Text] [Related]
9. A paradigm shift in enteric coating: achieving rapid release in the proximal small intestine of man. Liu F; Basit AW J Control Release; 2010 Oct; 147(2):242-5. PubMed ID: 20655342 [TBL] [Abstract][Full Text] [Related]
10. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets. Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950 [TBL] [Abstract][Full Text] [Related]
11. Effect of Calcium Ions on the Disintegration of Enteric-Coated Solid Dosage Forms. Al-Gousous J; Langguth P J Pharm Sci; 2016 Feb; 105(2):509-511. PubMed ID: 26523769 [TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor. Wong CY; Martinez J; Carnagarin R; Dass CR J Pharm Pharmacol; 2017 Mar; 69(3):285-294. PubMed ID: 28155991 [TBL] [Abstract][Full Text] [Related]
13. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet. Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763 [TBL] [Abstract][Full Text] [Related]
15. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends. Rujivipat S; Bodmeier R Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750 [TBL] [Abstract][Full Text] [Related]
16. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets. Vemula SK AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285 [TBL] [Abstract][Full Text] [Related]
17. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers. Merchant HA; Goyanes A; Parashar N; Basit AW Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730 [TBL] [Abstract][Full Text] [Related]
19. Pharmacomagnetography to evaluate the performance of magnetic enteric-coated tablets in the human gastrointestinal tract. Pinto LA; Corá LA; Rodrigues GS; Prospero AG; Soares GA; de Andreis U; de Arruda Miranda JR Eur J Pharm Biopharm; 2021 Apr; 161():50-55. PubMed ID: 33592280 [TBL] [Abstract][Full Text] [Related]
20. Towards a Better Understanding of the Post-Gastric Behavior of Enteric-Coated Formulations. Katona MT; Kakuk M; Szabó R; Tonka-Nagy P; Takács-Novák K; Borbás E Pharm Res; 2022 Jan; 39(1):201-211. PubMed ID: 35043354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]